Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 2
2004 5
2005 6
2007 8
2008 1
2009 6
2010 9
2011 9
2012 12
2013 17
2014 17
2015 21
2016 14
2017 18
2018 17
2019 18
2020 18
2021 32
2022 39
2023 52
2024 22

Text availability

Article attribute

Article type

Publication date

Search Results

298 results

Results by year

Filters applied: . Clear all
Page 1
Intrahepatic osteopontin signaling by CREBZF defines a checkpoint for steatosis-to-NASH progression.
Ma F, Liu Y, Hu Z, Xue Y, Liu Z, Cai G, Su W, Zheng Z, Fang X, Yan X, Ding D, Sun X, Jiang Y, Wei S, Li W, Zhao J, Zhang H, Li H, Xiao D, Zhang C, Ying H, Qin J, Gao X, Dai X, Fu W, Xu Y, Li Y, Cui A. Ma F, et al. Among authors: yan x. Hepatology. 2023 Nov 1;78(5):1492-1505. doi: 10.1097/HEP.0000000000000042. Epub 2023 Jan 3. Hepatology. 2023. PMID: 36680394
The nonautophagic functions of autophagy-related proteins.
Shang JN, Yu CG, Li R, Xi Y, Jian YJ, Xu N, Chen S. Shang JN, et al. Among authors: xi y. Autophagy. 2023 Sep 8:1-15. doi: 10.1080/15548627.2023.2254664. Online ahead of print. Autophagy. 2023. PMID: 37682088 Review.
Dalpiciclib plus letrozole or anastrozole versus placebo plus letrozole or anastrozole as first-line treatment in patients with hormone receptor-positive, HER2-negative advanced breast cancer (DAWNA-2): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Zhang P, Zhang Q, Tong Z, Sun T, Li W, Ouyang Q, Hu X, Cheng Y, Yan M, Pan Y, Teng Y, Yan X, Wang Y, Xie W, Zeng X, Wang X, Hu C, Geng C, Zhang H, Li W, Wu X, Zhong J, Xu J, Shi Y, Wei W, Bayaxi N, Zhu X, Xu B. Zhang P, et al. Among authors: yan x. Lancet Oncol. 2023 Jun;24(6):646-657. doi: 10.1016/S1470-2045(23)00172-9. Epub 2023 May 11. Lancet Oncol. 2023. PMID: 37182538 Clinical Trial.
Dalpiciclib or placebo plus fulvestrant in hormone receptor-positive and HER2-negative advanced breast cancer: a randomized, phase 3 trial.
Xu B, Zhang Q, Zhang P, Hu X, Li W, Tong Z, Sun T, Teng Y, Wu X, Ouyang Q, Yan X, Cheng J, Liu Q, Feng J, Wang X, Yin Y, Shi Y, Pan Y, Wang Y, Xie W, Yan M, Liu Y, Yan P, Wu F, Zhu X, Zou J; DAWNA-1 Study Consortium. Xu B, et al. Among authors: yan x. Nat Med. 2021 Nov;27(11):1904-1909. doi: 10.1038/s41591-021-01562-9. Epub 2021 Nov 4. Nat Med. 2021. PMID: 34737452 Clinical Trial.
Proline hydroxylation of CREB-regulated transcriptional coactivator 2 controls hepatic glucose metabolism.
Xue Y, Cui A, Wei S, Ma F, Liu Z, Fang X, Huo S, Sun X, Li W, Hu Z, Liu Y, Cai G, Su W, Zhao J, Yan X, Gao C, Wen J, Zhang H, Li H, Liu Y, Lin X, Xu Y, Fu W, Fang J, Li Y. Xue Y, et al. Among authors: yan x. Proc Natl Acad Sci U S A. 2023 Jun 6;120(23):e2219419120. doi: 10.1073/pnas.2219419120. Epub 2023 May 30. Proc Natl Acad Sci U S A. 2023. PMID: 37252972 Free PMC article.
Metabolic reprogramming of immune cells in pancreatic cancer progression.
Xiang H, Yang R, Tu J, Xi Y, Yang S, Lv L, Zhai X, Zhu Y, Dong D, Tao X. Xiang H, et al. Among authors: xi y. Biomed Pharmacother. 2023 Jan;157:113992. doi: 10.1016/j.biopha.2022.113992. Epub 2022 Nov 14. Biomed Pharmacother. 2023. PMID: 36395610 Free article. Review.
298 results